212 related articles for article (PubMed ID: 12498034)
1. [Neuroprotective effects of vinpocetine in vivo and in vitro. Apovincaminic acid derivatives as potential therapeutic tools in ischemic stroke].
Dézsi L; Kis-Varga I; Nagy J; Komlódi Z; Kárpáti E
Acta Pharm Hung; 2002; 72(2):84-91. PubMed ID: 12498034
[TBL] [Abstract][Full Text] [Related]
2. Asymptomatic ischemic cerebrovascular disorders and neuroprotection with vinpocetine.
Hadjiev D
Ideggyogy Sz; 2003 May; 56(5-6):166-72. PubMed ID: 12861957
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of hydroxysafflor yellow A: in vivo and in vitro studies.
Zhu H; Wang Z; Ma C; Tian J; Fu F; Li C; Guo D; Roeder E; Liu K
Planta Med; 2003 May; 69(5):429-33. PubMed ID: 12802724
[TBL] [Abstract][Full Text] [Related]
4. Evidence for neuroprotection by the fenamate NSAID, mefenamic acid.
Khansari PS; Halliwell RF
Neurochem Int; 2009 Dec; 55(7):683-8. PubMed ID: 19563851
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotection and glutamate attenuation by acetylsalicylic acid in temporary but not in permanent cerebral ischemia.
Berger C; Stauder A; Xia F; Sommer C; Schwab S
Exp Neurol; 2008 Apr; 210(2):543-8. PubMed ID: 18187132
[TBL] [Abstract][Full Text] [Related]
6. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
7. Oxyresveratrol (trans-2,3',4,5'-tetrahydroxystilbene) is neuroprotective and inhibits the apoptotic cell death in transient cerebral ischemia.
Andrabi SA; Spina MG; Lorenz P; Ebmeyer U; Wolf G; Horn TF
Brain Res; 2004 Aug; 1017(1-2):98-107. PubMed ID: 15261105
[TBL] [Abstract][Full Text] [Related]
8. The pre-ischaemic neuroprotective effect of a novel polyamine antagonist, N1-dansyl-spermine in a permanent focal cerebral ischaemia model in mice.
Li J; Henman MC; Doyle KM; Strbian D; Kirby BP; Tatlisumak T; Shaw GG
Brain Res; 2004 Dec; 1029(1):84-92. PubMed ID: 15533319
[TBL] [Abstract][Full Text] [Related]
9. Effect of aminoguanidine on post-ischemic damage in rodent model of stroke.
Vakili A; Zahedi-Khorasani M
Pak J Pharm Sci; 2008 Jan; 21(1):24-8. PubMed ID: 18166515
[TBL] [Abstract][Full Text] [Related]
10. Single and combined effects of carbamazepine and vinpocetine on depolarization-induced changes in Na+, Ca2+ and glutamate release in hippocampal isolated nerve endings.
Sitges M; Chiu LM; Nekrassov V
Neurochem Int; 2006 Jul; 49(1):55-61. PubMed ID: 16621162
[TBL] [Abstract][Full Text] [Related]
11. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport.
Hurtado O; Moro MA; Cárdenas A; Sánchez V; Fernández-Tomé P; Leza JC; Lorenzo P; Secades JJ; Lozano R; Dávalos A; Castillo J; Lizasoain I
Neurobiol Dis; 2005 Mar; 18(2):336-45. PubMed ID: 15686962
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic time window and dose dependence of neuroprotective effects of sodium orthovanadate following transient middle cerebral artery occlusion in rats.
Hasegawa Y; Morioka M; Hasegawa S; Matsumoto J; Kawano T; Kai Y; Yano S; Fukunaga K; Kuratsu J
J Pharmacol Exp Ther; 2006 May; 317(2):875-81. PubMed ID: 16461588
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of iNOS activity by 1400W decreases glutamate release and ameliorates stroke outcome after experimental ischemia.
Pérez-Asensio FJ; Hurtado O; Burguete MC; Moro MA; Salom JB; Lizasoain I; Torregrosa G; Leza JC; Alborch E; Castillo J; Knowles RG; Lorenzo P
Neurobiol Dis; 2005 Mar; 18(2):375-84. PubMed ID: 15686966
[TBL] [Abstract][Full Text] [Related]
15. Bis(7)-tacrine, a promising anti-Alzheimer's dimer, affords dose- and time-dependent neuroprotection against transient focal cerebral ischemia.
Zhao Y; Li W; Chow PC; Lau DT; Lee NT; Pang Y; Zhang X; Wang X; Han Y
Neurosci Lett; 2008 Jul; 439(2):160-4. PubMed ID: 18515007
[TBL] [Abstract][Full Text] [Related]
16. [In vivo exploration of cerebral ischemia: use of neuroprotective agents in animal studies].
Lestage P; Lockhart B; Roger A
Therapie; 2002; 57(6):554-63. PubMed ID: 12666263
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of the selective type 1 metabotropic glutamate receptor antagonist YM-202074 in rat stroke models.
Kohara A; Takahashi M; Yatsugi S; Tamura S; Shitaka Y; Hayashibe S; Kawabata S; Okada M
Brain Res; 2008 Jan; 1191():168-79. PubMed ID: 18164695
[TBL] [Abstract][Full Text] [Related]
18. [Neuroprotection by aspirin in cerebrovascular pathology].
Lorenzo Fernández P
An R Acad Nac Med (Madr); 2002; 119(2):311-20; discussion 320-6. PubMed ID: 12518657
[TBL] [Abstract][Full Text] [Related]
19. Vinpocetine. Monograph.
Altern Med Rev; 2002 Jun; 7(3):240-3. PubMed ID: 12126465
[No Abstract] [Full Text] [Related]
20. A novel potent radical scavenger, 8-(4-fluorophenyl)-2-((2E)-3-phenyl-2-propenoyl)-1,2,3,4-tetrahydropyrazolo[5,1-c] [1,2,4]triazine (FR210575), prevents neuronal cell death in cultured primary neurons and attenuates brain injury after focal ischemia in rats.
Iwashita A; Maemoto T; Nakada H; Shima I; Matsuoka N; Hisajima H
J Pharmacol Exp Ther; 2003 Dec; 307(3):961-8. PubMed ID: 14534357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
